Connect Biopharma Holdings Ltd (CNTB) — Financial Flexibility Index
Connect Biopharma Holdings Ltd (CNTB) has a Financial Flexibility Index of -0.92x as of March 2026. Free cash flow of $-16.00 Million (operating CF $-16.00 Million minus capex $0.00) represents -1% of total liabilities ($17.44 Million). Check CNTB capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Connect Biopharma Holdings Ltd Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Connect Biopharma Holdings Ltd across 8 annual periods. See CNTB net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Connect Biopharma Holdings Ltd (2018–2025)
Year-by-year free cash flow to debt coverage for Connect Biopharma Holdings Ltd. For the full company profile including market capitalisation, see CNTB market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.60x | $-50.77 Million | $-51.21 Million | $14.10 Million | ▼ -43.7% |
| 2024 | -2.51x | $-22.86 Million | $-23.61 Million | $9.12 Million | ▼ -36.2% |
| 2023 | -1.84x | $-47.64 Million | $-47.93 Million | $25.88 Million | ▲ +68.0% |
| 2022 | -5.75x | $-94.99 Million | $-99.27 Million | $16.52 Million | ▲ +78.3% |
| 2021 | -26.46x | $-497.40 Million | $-544.93 Million | $18.80 Million | ▼ -5527.8% |
| 2020 | -0.47x | $-23.26 Million | $-25.61 Million | $49.47 Million | ▲ +49.4% |
| 2019 | -0.93x | $-12.94 Million | $-13.09 Million | $13.91 Million | ▼ -21.6% |
| 2018 | -0.76x | $-67.84 Million | $-69.03 Million | $88.70 Million | — |